| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alternating chemotherapy with VDC-IE as effective first-line treatment in a patient with SMARCA4-deficient undifferentiated tumor
|
Popov, Petar
|
|
|
17 |
4 |
p. 307-309
|
article
|
| 2 |
Can artificial intelligence provide accurate and reliable answers to cancer patients’ questions about cancer pain? Comparison of chatbots based on ESMO cancer pain guideline
|
Bir Yücel, Kadriye
|
|
|
17 |
4 |
p. 302-306
|
article
|
| 3 |
CAR-T cell therapy for relapsed or refractory multiple myeloma in 2024—clinically available treatment options in Austria
|
Strassl, Irene
|
|
|
17 |
4 |
p. 242-246
|
article
|
| 4 |
Escalation of neoadjuvant therapy in triple-negative breast cancer—balancing effectiveness and toxicities
|
Suppan, Christoph
|
|
|
17 |
4 |
p. 251-253
|
article
|
| 5 |
GATA2 deficiency: a mystery myelodysplasia
|
Shoaib, Raqiya
|
|
|
17 |
4 |
p. 315-321
|
article
|
| 6 |
Impact of the WHO-5 classification of haematolymphoid tumours on clinical practice
|
Brand, Rosa
|
|
|
17 |
4 |
p. 269-273
|
article
|
| 7 |
Importance of genetic clarification in cytopenia syndromes (childhood myelodysplastic syndrome forms)
|
Novak, Wolfgang
|
|
|
17 |
4 |
p. 297-301
|
article
|
| 8 |
KRAS: Finally a druggable target in oncology?
|
Ilhan-Mutlu, Aysegul
|
|
|
17 |
4 |
p. 239
|
article
|
| 9 |
KRAS (Kirsten rat sarcoma) in modern oncology—The molecular pathological point of view
|
Schmitz, Katja
|
|
|
17 |
4 |
p. 287-291
|
article
|
| 10 |
NEC versus NET G3—is there a grey zone? Case report of pancreatic NET G3 with rapid disease progression
|
Melhorn, Philipp
|
|
|
17 |
4 |
p. 310-314
|
article
|
| 11 |
New therapy options for myelodysplastic syndrome—all for all or targeted?
|
Petzer, Verena
|
|
|
17 |
4 |
p. 254-256
|
article
|
| 12 |
Next generation of drugs in breast cancer
|
Bartsch, Rupert
|
|
|
17 |
4 |
p. 280-286
|
article
|
| 13 |
Not only a chicken and egg problem in children with pancytopenia
|
Dworzak, Michael N.
|
|
|
17 |
4 |
p. 240-241
|
article
|
| 14 |
Recent developments in marginal zone lymphoma
|
Raderer, Markus
|
|
|
17 |
4 |
p. 247-250
|
article
|
| 15 |
State-of-the-art therapy and innovative treatment strategies in esophageal squamous cell cancer
|
Korpan, Martin
|
|
|
17 |
4 |
p. 274-279
|
article
|
| 16 |
Treatment sequencing in gastroenteropancreatic neuroendocrine tumors
|
Melhorn, Philipp
|
|
|
17 |
4 |
p. 257-262
|
article
|
| 17 |
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
|
Doleschal, Bernhard
|
|
|
17 |
4 |
p. 292-296
|
article
|
| 18 |
Updates and changes in the treatment of cervical cancer
|
Danisch, M.
|
|
|
17 |
4 |
p. 263-268
|
article
|
Journal description